Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
NX-2127
i
Other names:
NX-2127
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Nurix Therap
Drug class:
IKZF1 degrader, IKZF3 degrader, BTK degrader
Related drugs:
‹
KT-413 (5)
CFT7455 (1)
SP-3164 (0)
ABBV-101 (1)
BGB-16673 (0)
HSK29116 (0)
NX-5948 (0)
KT-413 (5)
CFT7455 (1)
SP-3164 (0)
ABBV-101 (1)
BGB-16673 (0)
HSK29116 (0)
NX-5948 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
BCL2 mutation
Chronic Lymphocytic Leukemia
BCL2 mutation
Chronic Lymphocytic Leukemia
NX-2127
Sensitive: C3 – Early Trials
NX-2127
Sensitive
:
C3
NX-2127
Sensitive: C3 – Early Trials
NX-2127
Sensitive
:
C3
BTK mutation
Chronic Lymphocytic Leukemia
BTK mutation
Chronic Lymphocytic Leukemia
NX-2127
Sensitive: C3 – Early Trials
NX-2127
Sensitive
:
C3
NX-2127
Sensitive: C3 – Early Trials
NX-2127
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login